Mairs & Power’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
Mairs & Power's NWBO Position: Q2 2020 in Review
Mairs & Power sold out of Northwest Biotherapeutics (NWBO) in Q2 2020, closing a stake of 12,500 shares — an estimated $2K sold.
Mairs & Power first reported a position in NWBO in Q4 2015 and held it in 18 quarters. The position peaked at $40K in Q4 2015. 5 funds tracked by Wall St. Rank hold NWBO as of Q2 2020.
- Mairs & Power reported no remaining Northwest Biotherapeutics position as of Q2 2020 after selling out during the quarter.
- Mairs & Power sold 12,500 Northwest Biotherapeutics shares in Q2 2020, an estimated $2K.
- Mairs & Power first reported a position in Northwest Biotherapeutics in Q4 2015 and held it in 18 quarters.
- Mairs & Power's Northwest Biotherapeutics position peaked at $40K in Q4 2015.
- 5 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q2 2020.
Based on Mairs & Power's 13F filing for Q2 2020, filed 14 Aug 2020.